TY  - JOUR 
AU  - Lapitz, Ainhoa
AU  - Azkargorta, Mikel
AU  - Milkiewicz, Piotr
AU  - Olaizola, Paula
AU  - Zhuravleva, Ekaterina
AU  - Grimsrud, Marit M
AU  - Schramm, Christoph
AU  - Arbelaiz, Ander
AU  - O'Rourke, Colm J
AU  - La Casta, Adelaida
AU  - Milkiewicz, Malgorzata
AU  - Pastor, Tania
AU  - Vesterhus, Mette
AU  - Jimenez-Agüero, Raul
AU  - Dill, Michael T
AU  - Lamarca, Angela
AU  - Valle, Juan W
AU  - Rodríguez Macías, Rocío Isabel
AU  - Izquierdo-Sanchez, Laura
AU  - Pérez Castaño, Ylenia
AU  - Caballero-Camino, Francisco Javier
AU  - Riaño, Ioana
AU  - Krawczyk, Marcin
AU  - Ibarra, Cesar
AU  - Bustamante, Javier
AU  - Nova-Camacho, Luiz M
AU  - Falcon-Perez, Juan M
AU  - Elortza, Felix
AU  - Perugorria, Maria J
AU  - Andersen, Jesper B
AU  - Bujanda, Luis
AU  - Karlsen, Tom H
AU  - Folseraas, Trine
AU  - Rodrigues, Pedro M
AU  - Banales, Jesus M.
PY  - 2023
UR  - http://hdl.handle.net/10366/155299
AB  - Cholangiocarcinoma (CCA), heterogeneous biliary tumours with dismal prognosis, lacks accurate early diagnostic methods especially important for individuals at high-risk (i.e. those with primary sclerosing cholangitis [PSC]). Here, we searched for...
LA  - eng
KW  - cholangiocarcinoma
KW  - biomarker
KW  - Liver Neoplasms
KW  - Early Diagnosis
KW  - Cholangiocarcinoma
KW  - Cholangitis
KW  - Carcinoma
KW  - Humans
KW  - Bile Ducts
KW  - Carbohydrates
KW  - Bile Duct Neoplasms
KW  - Nuclear Proteins
TI  - Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
DO  - 10.1016/j.jhep.2023.02.027
T2  - Journal of hepatology
VL  - 79
M2  - 93
ER  -